Chart your course with
ordering & reimbursement

Please order VANTAS through Besse Medical
Here is a step-by-step guide

Ordering VANTAS is easy

Call Besse Medical to place an order. Confirm the following information: bill-to address, ship-to address, and delivery date. Receive a confirmation number for your order.

If you do not currently order from this supply house, you may need to open a new account. This process does include a credit check. Please contact the supply house through the telephone number listed below:

VANTAS is shipped overnight for arrival on the expected delivery date.

Besse Medical bills you for the order. The bill will be sent to the address given at the time of order.

Account billing procedure will be changed and will require an account at Besse Medical. If your office needs assistance setting up a new account, your Indevus Pharmaceuticals representative can assist you. Credit cards will still be accepted for VANTAS.

See VANTAS Implant Dosing & Administration for storage instructions
once you receive your order

For downloadable instructions on how to place orders of the
VANTAS implant, click below:

Important Safety Information

VANTAS is contraindicated in women, pediatric patients and patients with hypersensitivity to GnRH, GnRH agonist analogs, or any of the other components of VANTAS.

VANTAS, like other LHRH agonists, causes a transient increase in serum concentrations of testosterone during the first week of treatment. Patients may experience worsening of symptoms or onset of new symptoms, including bone pain, neuropathy, hematuria, or ureteral or bladder outlet obstruction, cases of ureteral obstruction and spinal cord compression. Patients with metastatic vertebral lesions and/or with urinary tract obstruction should be closely observed during the first few weeks of therapy.

Implant insertion and removal is a surgical procedure and should use aseptic technique. Careful adherence to the recommended insertion and removal procedures is recommended. In all clinical trials combined, an implant was not recovered in 8 patients, 2 of these 8 patients had serum testosterone levels above castrate level and the implant was not visualized with ultrasound. In all of the 8 patients, the implant was not palpable.

Response to VANTAS should be monitored measuring serum concentrations of testosterone and PSA periodically.

In clinical trials, the most common adverse reactions were hot flashes, fatigue, and implant site reaction. During post-marketing surveillance, rare cases of pituitary apoplexy have been reported after the administration of GnRH agonists.

Chart your course with ordering & reimbursement

Click here for a larger view

Important Safety Information

Chart your course with
ordering & reimbursement